TAC (mmol/L) |
Initial |
0.95 (0.10) |
0.80 (0.15) |
-0.15 ( -0.56 to
0.10) |
|
End |
1.10 (0.10) |
1.45 (0.35) a , b
|
0. 35 (0. 10
to 0.43) |
|
MD (95% CI) within groups |
0.15 (-0.31 to 0. 20) |
0.65 (-0.82 to
-0. 50) |
|
SOD (U/mg Hb) |
Initial |
1627.32 (142.90) |
1604.75 (97.21) |
-22.55(-52.20 to 97.35) |
|
End |
1609.65 (154.25) |
1774.20 (105.50) a, b
|
165.50 (84.8 to 109.9) |
|
MD (95% CI) within groups |
-17.98 (-42.57 to 78.55) |
169.45
(-218.40 to -121.20) |
|
GSH-Px (U/g Hb) |
Initial |
33.53 (3.0) |
32.96 (2.31) |
0.60 (-1.07 to
2.21) |
|
End |
33.45 (3.34) |
35.60 (3.65) a
|
2.15 (-4.30 to
0.32) |
|
MD (95% CI) within groups |
-0.08 (-0.70 to 0.85) |
2.64 (-3.99 to
-1.25) |
|
Catalase (U/g Hb) |
Initial |
64.20 (18.17) |
59.70 (17.20) |
-4. 50
(-3.20 to 17.50) |
|
End |
66.79 (16.60) |
73.60 (26.55) |
6.81 (-23.46 to
4.70) |
|
MD (95% CI) within groups |
2.59 (-7.93 to 13.15) |
-13.90 (-23.65 to
4.12) |
|
Uric acid (mg/dL) |
Initial |
4.60 (1.26) |
4.75 (1.23) |
0.15 (-0.91 to
0.62) |
|
End |
4.50 (1.33) |
4.80 (1.20) |
0.40 (-1.10 to 0.45) |
|
MD (95% CI) within groups |
-0.10 (-0.14 to 0..40) |
0.15 (-0.39 to
0.26) |
|
MDA (nmol/mL) |
Initial |
3.85 (0.84) |
3.64 (1.42) |
-0.25 (-0.56 to
0.93) |
|
End |
3.68 (0.68) |
2.99 (1.16) a , b
|
-0.70 (-0.25
to -1.20) |
|
MD (95% CI) within groups |
-0.17 (-0.23 to 0.56) |
-0.65 (-0.50 to
-1.21) |
|
8-iso-PGF2α (pg/ml) |
Initial |
33.60 (7.03) |
30.15 (4.50) |
-3.30
(-11.80 to 6.50) |
|
End |
31.20 (5.15) |
25.10 (4.15) a , b
|
-6.65
(-8.45 to -5.40) |
|
MD (95% CI) within groups |
-2.4.0 (-9.15 to 8.20) |
-4.90 (-8.05 to
-4.60) |
|